相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Proteasome inhibitors in progressive renal diseases
Rosanna Coppo
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Staging and prognostication of multiple myeloma
Rafael Fonseca et al.
EXPERT REVIEW OF HEMATOLOGY (2014)
miR-202 expression concentration and its clinical significance in the serum of multiple myeloma patients
Jiajia Yu et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Multiple myeloma: the bone marrow microenvironment and its relation to treatment
S. W. Andrews et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2013)
Quality of Life and Supportive Care in Multiple Myeloma
Melda Comert et al.
TURKISH JOURNAL OF HEMATOLOGY (2013)
Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management
S. Vincent Rajkumar
AMERICAN JOURNAL OF HEMATOLOGY (2012)
B cell-activating factor: its clinical significance in multiple myeloma patients
M. Fragioudaki et al.
ANNALS OF HEMATOLOGY (2012)
BLyS expression and JNK activation may form a feedback loop to promote survival and proliferation of multiple myeloma cells
G. Xu et al.
CYTOKINE (2012)
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies
Lidia Rita Corsini et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma
M. Fragioudaki et al.
LEUKEMIA RESEARCH (2012)
miR-15a and miR-16-1 inhibit the proliferation of leukemic cells by down-regulating WT1 protein level
Shen-meng Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
MicroRNA signatures characterize multiple myeloma patients
S. L. Corthals et al.
LEUKEMIA (2011)
Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
Mu Hao et al.
LEUKEMIA & LYMPHOMA (2011)
Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways
T. Kobayashi et al.
LEUKEMIA (2010)
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition
Jianguo Wen et al.
LEUKEMIA RESEARCH (2010)
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
Yuhuan Zheng et al.
BLOOD (2009)
Correlation of expression levels of BLyS and its receptors with multiple myeloma
Shaoqing Ju et al.
CLINICAL BIOCHEMISTRY (2009)
B-Lymphocyte stimulator: a new biomarker for multiple myeloma
Pu Jiang et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Bone marrow microenvironment and the identification of new targets for myeloma therapy
K. Podar et al.
LEUKEMIA (2009)
The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance
Mark B. Meads et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma
Richard I. Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment
Yu-Tzu Tai et al.
CANCER RESEARCH (2006)
分享论文
